Website: www.oncoai.com.br

Founded in 2023, OncoAI is dedicated to transforming the fight against cancer. Inspired by the doctoral research of its founding partner, who developed a method for predicting recurrence in superficial bladder cancer, the company has expanded its focus to breast and lung neoplasms—among the most impactful cancers in Brazil and worldwide.

OncoAI's mission is to leverage advanced artificial intelligence techniques to enhance cancer diagnosis, treatment, and patient outcomes.

OncoAI offers innovative solutions aimed at improving cancer care, with a focus on:

• Recurrence Prediction: Utilizing AI to predict cancer recurrence, aiding in early intervention strategies.

• Breast and Lung Cancer Analysis: Developing tools to assist in the diagnosis and treatment planning for breast and lung cancers.

For more information, visit our website: www.oncoai.com.br